406 related articles for article (PubMed ID: 28756524)
1. Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration.
Attia M; Maurer M; Robinet M; Le Grand F; Fadel E; Le Panse R; Butler-Browne G; Berrih-Aknin S
Acta Neuropathol; 2017 Dec; 134(6):869-888. PubMed ID: 28756524
[TBL] [Abstract][Full Text] [Related]
2. IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis.
Maurer M; Bougoin S; Feferman T; Frenkian M; Bismuth J; Mouly V; Clairac G; Tzartos S; Fadel E; Eymard B; Fuchs S; Souroujon MC; Berrih-Aknin S
Acta Neuropathol Commun; 2015 Jan; 3():1. PubMed ID: 25627031
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?
Baggi F; Antozzi C; Toscani C; Cordiglieri C
Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):19-30. PubMed ID: 22159475
[TBL] [Abstract][Full Text] [Related]
5. Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravis.
Hu B; Simon-Keller K; Küffer S; Ströbel P; Braun T; Marx A; Porubsky S
Exp Neurol; 2016 Mar; 277():76-85. PubMed ID: 26708556
[TBL] [Abstract][Full Text] [Related]
6. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
[TBL] [Abstract][Full Text] [Related]
7. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.
Meinen S; Lin S; Rüegg MA; Punga AR
PLoS One; 2012; 7(8):e44148. PubMed ID: 22952904
[TBL] [Abstract][Full Text] [Related]
8. Treatment of passively transferred experimental autoimmune myasthenia gravis using papain.
Poulas K; Tsouloufis T; Tzartos SJ
Clin Exp Immunol; 2000 May; 120(2):363-8. PubMed ID: 10792389
[TBL] [Abstract][Full Text] [Related]
9. mTOR is necessary for proper satellite cell activity and skeletal muscle regeneration.
Zhang P; Liang X; Shan T; Jiang Q; Deng C; Zheng R; Kuang S
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):102-8. PubMed ID: 25998386
[TBL] [Abstract][Full Text] [Related]
10. Animal models of myasthenia gravis.
Christadoss P; Poussin M; Deng C
Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
[TBL] [Abstract][Full Text] [Related]
11. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis.
Asher O; Kues WA; Witzemann V; Tzartos SJ; Fuchs S; Souroujon MC
J Immunol; 1993 Dec; 151(11):6442-50. PubMed ID: 8245477
[TBL] [Abstract][Full Text] [Related]
12. Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.
Fuchs S; Aricha R; Reuveni D; Souroujon MC
J Autoimmun; 2014 Nov; 54():51-9. PubMed ID: 24970384
[TBL] [Abstract][Full Text] [Related]
13. Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
Oshima M; Iida-Klein A; Maruta T; Deitiker PR; Atassi MZ
Autoimmunity; 2017 Sep; 50(6):346-353. PubMed ID: 28850269
[TBL] [Abstract][Full Text] [Related]
14. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
Meinl E; Klinkert WE; Wekerle H
Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
[TBL] [Abstract][Full Text] [Related]
15. Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.
Tüzün E; Allman W; Ulusoy C; Yang H; Christadoss P
Ann N Y Acad Sci; 2012 Dec; 1274():133-9. PubMed ID: 23252908
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine receptor-alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis?
Sheng JR; Li LC; Prabhakar BS; Meriggioli MN
Muscle Nerve; 2009 Aug; 40(2):279-86. PubMed ID: 19609914
[TBL] [Abstract][Full Text] [Related]
17. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
[TBL] [Abstract][Full Text] [Related]
18. Experimental autoimmune myasthenia gravis in the mouse.
Wu B; Goluszko E; Huda R; Tüzün E; Christadoss P
Curr Protoc Immunol; 2013; Chapter 15():Unit 15.8.. PubMed ID: 23392639
[TBL] [Abstract][Full Text] [Related]
19. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH
J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206
[TBL] [Abstract][Full Text] [Related]
20. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
